Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
|
|
35.
|
|
|
36.
|
|
|
37.
|
|
|
38.
|
ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. [electronic resource] by
- Burgess, R
- MacLaren, R E
- Davidson, A E
- Urquhart, J E
- Holder, G E
- Robson, A G
- Moore, A T
- Keefe, R O'
- Black, G C M
- Manson, F D C
Producer: 20091231
In:
Journal of medical genetics vol. 46
Availability: No items available.
|
|
39.
|
First-in-human study of the safety and viability of intraocular robotic surgery. [electronic resource] by
- Edwards, T L
- Xue, K
- Meenink, H C M
- Beelen, M J
- Naus, G J L
- Simunovic, M P
- Latasiewicz, M
- Farmery, A D
- de Smet, M D
- MacLaren, R E
Publication details: Nature biomedical engineering Jun 2018
In:
Nature biomedical engineering vol. 2
Availability: No items available.
|
|
40.
|
EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV. [electronic resource] by
- Balaggan, K S
- Binley, K
- Esapa, M
- MacLaren, R E
- Iqball, S
- Duran, Y
- Pearson, R A
- Kan, O
- Barker, S E
- Smith, A J
- Bainbridge, J W B
- Naylor, S
- Ali, R R
Producer: 20070118
In:
Gene therapy vol. 13
Availability: No items available.
|